Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
California, United States
Countries of investment
  • USA
  • United Kingdom
  • France
  • Ireland
Investment stages
  • Series A
Industries
  • Health Tech
  • Biotechnology
  • AI
  • Data science
About
Illumina Ventures is a genomics-focused firm investing in pioneering tools, therapeutics, and diagnostics to advance precision medicine.
Min check size
$500K
Max check size
$1M
Fund size
NPS

Investment Thesis

They invest globally in pioneering companies in genomics and precision health, in markets such as life science tools, clinical diagnostics, therapeutics, digital health, and other areas impacted by genomics.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Leveraging extensive expertise in venture capital, the fund manager has successfully executed over 50 investments across sectors such as technology, healthcare, and consumer products. With a strong presence in North America and Europe, their strategic style emphasizes a data-driven approach, targeting early to growth-stage companies. Notable exits include several high-profile IPOs and mergers, showcasing a robust track record of value creation. Their operator-first philosophy ensures a hands-on involvement in portfolio companies, driving sustainable growth and innovation.

Illumina Ventures Contacts Information

Primary contact

Secondary contact

Team

Wouter Meuleman

Omer Ayfer

Donal Delaney

Cindy Munn

Wouter Meuleman

Thomas Willis

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp